Our data show mRNA and cytoplasmic CTLA-4 expression in all primary melanoma cell lines tested, although the surface CTLA-4 expression was quite heterogeneous (MRFI ranging from 1.2 to 6.9), regardless their stage of differentiation and stemness phenotype. The gene discussed is CTLA4; the disease is melanoma.